Study Confirms Efficacy of Stratum’s NEM for Joint Health

Empty egg shells after the chicken has hatched and left, isolated on a white background

Carthage, MO—Stratum Nutrition has announced in a press release the publication of the third independent study for their joint health ingredient NEM, which confirms its efficacy.

The single-center, two-month, open-label study was published in the Journal of Arthritis. It was performed on 70 patients with mild to moderate knee osteoarthritis. Patients saw statistically significant reductions in WOMAC pain, VAS pain, and Lequesne Algofunctional Index pain after only 10 days of supplementation; by the end of the study, those reductions in pain reached 52%, 49%, and 39%, respectively.

Related: Study Shows Efficacy of Stratum’s NEM
Bone & Joint Support for Every Generation
Stratum Nutrition Announces Alliance with 3i Solutions

Furthermore, the researchers noted that after 60 days of supplementation, there were no differences in overall WOMAC scores or overall Lequesne scores between patients with Kellgren-Lawrence (KL) grade 1, grade 2, or grade 3 osteoarthritis—meaning that the symptoms of KL grade 3 osteoarthritis sufferers improved so substantially that they had the symptoms of KL grade 1 osteoarthritis after supplementing with NEM for two months.